title: Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy.
authors.forename: Benjamin G
authors.initials: BG
authors.lastname: Oliver
authors.forename: Lewis J
authors.initials: LJ
authors.lastname: Haddow
authors.forename: Upasna
authors.initials: U
authors.lastname: Agarwal
authors.forename: Manoj
authors.initials: M
authors.lastname: Kumar
authors.forename: Philippa J
authors.initials: PJ
authors.lastname: Easterbrook
authors.forename: Mahomed-Yunus
authors.initials: MY
authors.lastname: Moosa
authors.forename: Sarman
authors.initials: S
authors.lastname: Singh
authors.forename: Patricia
authors.initials: P
authors.lastname: Price
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018932:Chemokine CCL2 / Q000097:blood*; D054357:Chemokine CXCL10 / Q000097:blood; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000150:complications / Q000175:diagnosis*; D020382:Interleukin-18 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D018950:Lipopolysaccharide Receptors / Q000097:blood; D008262:Macrophage Activation; D009169:Mycobacterium tuberculosis / Q000276:immunology; D018375:Neutrophil Activation; D011379:Prognosis; D014376:Tuberculosis / Q000150:complications / Q000276:immunology*
chemical_list: D019380:Anti-HIV Agents; C111835:CCL2 protein, human; C114753:CXCL10 protein, human; C508606:CXCL8 protein, human; D018932:Chemokine CCL2; D054357:Chemokine CXCL10; D020382:Interleukin-18; D016209:Interleukin-8; D018950:Lipopolysaccharide Receptors